Ondansetron and pregnancy: possible congenital heart defects.
Two cohort studies, including more than 2500 pregnant women exposed to ondansetron in early pregnancy, have raised concerns over an increased risk of congenital heart defects.
D005260:Female; D006330:Heart Defects, Congenital / Q000139:chemically induced*; D006801:Humans; D017294:Ondansetron / Q000009:adverse effects*; D011247:Pregnancy; D058831:Serotonin 5-HT3 Receptor Antagonists / Q000009:adverse effects*
D058831:Serotonin 5-HT3 Receptor Antagonists; D017294:Ondansetron